Connect with us

News and Report

UBA Appoints five new Executive Directors to Group Board .

Published

on

nited Bank for Africa PLC, the leading pan Africa banking group, with operations in 19 African countries and presence in the London, Paris and New York, is pleased to announce the following executive management appointments, subject to the approval of the Central Bank of Nigeria:

Ayo Liadi;

Oliver Alawuba;

Ibrahim Puri;

Uche Ike and

Chuks Nweke

All bring considerable experience to the Board and, as a sign of the depth of internal talent and the Group’s commitment to fostering promotion of its own human capital , all have been promoted from within the Bank.

Ayo Liadi has over 20 years’ banking experience, having worked in Tier 1 banks in Nigeria and in West Africa, before joining UBA in January 2014 as the Director for Lagos and West Bank, overseeing over 200 branches of UBA. A Chartered Accountant and graduate of Business Management from the University of Nigeria, Nsukka, Ayo received the Dean’s Award for Outstanding Academic Performance.

Oliver Alawuba, currently the CEO Africa, Anglophone, joined the UBA Group in 1997. A member of the Association of Bank Directors in Nigeria and also a Catholic Knight, Oliver had previously supervised the Bank’s Public Sector and Personal Banking businesses. Oliver has over 25 years of banking experience.

Ibrahim Puri, currently Directorate Head of the North Bank is a graduate of Banking and Finance. He joined the UBA Group in 2006 and has contributed immensely to the growth of the Bank in both the private and public sectors. Ibrahim has over 25 years of banking experience.

Uche Ike  the Group Chief Risk Officer, is a Chartered Accountant, with an MBA from the University of Benin. He has been with the Group since 2006 and has served in a number of prominent roles, first as Group Head of Operations in South and South East Banks and then for a period of five years, as General Manager at the Bank’s New York branch. Uche has over 27 years of banking experience.

Chuks Nweke, currently the Head of Operations and Information Technology, is an accounting graduate of the University of Nigeria at Nsukka (best graduating student) and holds an MBA from the same university. Chuks is also a qualified Chartered Accountant. He has over 25 years of banking experience .

Congratulating the newly appointed Directors, the Group Chairman, Tony Elumelu said ” These appointments will greatly assist in the plans we have to transform the UBA Group into a truly customer led bank and the foremost financial institution in Africa”.

“These are exciting times for UBA”, he continued. “And with this leadership, I have no doubt that the Bank will continue on its strong growth trajectory “.

The newly appointed Executive Directors join Kennedy Uzoka, who was appointed as the incoming Group CEO in March 2016. Kennedy will assume his role on the 1st of August, on the retirement of Phillips Oduoza.

Mr Uzoka said today “I am extremely optimistic about the future of the Bank, these appointments show the strength of the talent available within UBA and demonstrate our commitment to institutionalisation. We could not have put together a better executive leadership team”.

Board Chairman, Tony Elumelu, also commended outgoing Directors saying “I take this opportunity to inform you that two of our Executive Directors, Femi Olaloku and Obi Ibekwe will be retiring from the Board effective June 30 and May 31, 2016 respectively. I would like to thank them for the enormous contributions they have made during their time of service”.

In April this year, UBA held an intensive three day strategy session which brought together the Group Board , subsidiary CEOs and board chairs to set a path for the Pan Africa Bank’s future.

At the Group strategy session, the Bank resolved to deepen its commitment to its pan Africa strategy and accelerate its expansion across the continent. The appointment of five Executive Directors today is a visible manifestation of the Group’s strategic intent.

UBA reported strong financial results in 2015, in what all recognised was a challenging macro environment. Gross earnings were N315billion whilst operating profits approximated to N70billion. First quarter profits in the current financial year, at N18 billion, illustrate the resilience of the Bank’s business model.

Continue Reading
Advertisement

News and Report

Beware of fake Oxycontin in circulation, NAFDAC warns public

Published

on

By

The National Agency for Food and Drug Administration and Control has alerted the public on falsified Oxycontin 80mg (oxycodone hydrochloride) which it says was detected in an unregulated market in Switzerland.

The public alert with No. 07/2025 was uploaded on the agency’s website on Thursday.
The agency said the issue about falsified medicine was reported to the World Health Organisation by the genuine manufacturer, MUNDIPHARMA, in February.

It said the falsified product imitated the genuine OXYCONTIN 80mg authorised for sale in Poland, adding that the genuine OXYCONTIN (oxycodone hydrochloride) is a semi-synthetic opioid indicated for the treatment of moderate to severe pain.

It said laboratory tests of samples for the falsified product were conducted by the Drug Information Centre in Zurich, Switzerland, and that WHO, DIZ’s drug-checking service determined that the tablets did not contain oxycodone but a synthetic opioid likely to be a nitazene compound.

According to NAFDAC, Nitazene derivatives (e.g., metonitazene, isotonitazene, fluonitazene) are potent synthetic opioids, primarily used in research due to their high addiction potential and severe side effects.

It said these substances could be hundreds of times stronger than oxycodone, posing a high overdose risk, stressing that limited information is available on their risks, toxicity, side effects, and long-term consequences.

“The identified product in this alert is confirmed as falsified on the basis that it deliberately/fraudulently misrepresented its identity, composition, or source.

“The falsified product imitates OXYCONTIN 80mg manufactured and marketed by MUNDIPHARMA in the Polish market. MUNDIPHARMA has confirmed that the product was falsified and was not produced by their company.

“This falsified product has been found to contain undeclared nitazene compounds, which pose a significant risk due to the high likelihood of adverse events, even in small doses. Nitazenes produce similar effects to other opioids.

“Their high potency carries a high risk of overdose and death. Using nitazene derivatives has been linked to several deaths.

“Mixing them with other depressants like alcohol or benzodiazepines can be very dangerous, leading to severe effects like respiratory depression, low blood pressure, coma, or even death,” NAFDAC said.

It said that this falsified product posed a particular risk to individuals with substance use disorders who might perceive this falsified product as a safe and quality-assured medicine.

NAFDAC said that visible discrepancies were observed on the falsified product such as the placement of the batch and expiry dates on the counterfeit product were incorrect.

It added that the falsified product batch and expiry date are visible on the front side of the blister strip, adding that genuine OXYCONTIN has the batch and expiry date visible on the back of the blister strip.

NAFDAC stated that on the falsified product, the expiry date is on the left and the batch number is on the right, pointing out that genuine OXYCONTIN has the batch number on the left and the expiry date on the right.

According to NAFDAC, all its zonal directors and state coordinators have been instructed to conduct surveillance and retrieve any falsified products of this medicine found within their zones and states in Nigeria.

It said that importers, distributors, retailers, healthcare professionals, and consumers are hereby advised to exercise caution and vigilance within the supply chain to avoid importation, distribution, sale, and use of falsified OXYCONTIN tablets.

NAFDAC said that all medical products/ medical devices must be obtained from authorised/licensed suppliers, stressing that products’ authenticity and physical condition should be carefully checked.

It advised healthcare professionals and consumers to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, or call NAFDAC on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng.

It said that healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office.

NAFDAC said that healthcare professionals and patients could also report to the agency through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng

NAN

Continue Reading

News and Report

Rivers emergency rule: Why I walked out – Senator Dickson opens up on what happened at Senate close section

Published

on

By

The lawmaker representing the Bayelsa West Senatorial District, Senator Seriake Dickson, has revealed that he walked out of the red chamber on Thursday following a heated argument regarding the approval of the State of Emergency in Rivers State.

SOCIETY REPORTERS reports that the Senate on Thursday approved the emergency rule and the six-month suspension of Governor Siminalayi Fubara, his deputy, and all the state lawmakers, as declared by President Bola Tinubu on Tuesday.

During the Thursday plenary, Senator Dickson, who stiffly opposed the proclamation, had a brief argument with the President of the Senate, Senator Godswill Akpabio, before the House proceeded to a closed session.

In a statement on Friday, Senator Dickson revealed that he raised his “objections in the closed session on how the declaration fell short of constitutional prescription based on my views as a Democrat, sworn to uphold the Nigerian constitution.”

The lawmaker also revealed that though the Senate did not undertake the debate in an open session, “it was quite robust.”

The former governor of Bayelsa State listed Senators Waziri Tambuwal and Enyinnaya Abaribe among those who kicked against the proclamation.

Part of the statement reads: “I left the plenary before the Senate President was directed to report the outcome because I didn’t want to be present while what I opposed was being reported. I believe Senator Tambuwal, Senator Abaribe, and others also left.

“I want to make it clear that, as I stated repeatedly, I spoke and voted against the proclamation in our closed session, supported by Senator Aminu Tambuwal and a few other senators who were not recognized to speak.

“And so I want to thank all the senators who shared the view that I vigorously canvassed.

“I am, however, aware of the efforts made to modify the declaration as a result of the concerns and views we have expressed and canvassed over the past few days.

“Though I acknowledge the effort being made by the leadership and the President to moderate the terms of the declaration and to create a mechanism for oversight, theoretically, this does not counter the primary issue of constitutionality.

“The beauty of democracy is such that the minority will have their say while the majority will have their way.

“I would have wished for a more robust and open debate so that all views and opinions could be openly canvassed, as I requested even at the closed session specifically, and thereafter, the majority could have their way. But as it is, both chambers have decided, and the ball is now in the court of the other arms of government, especially the judiciary, in the event of any challenge.”

Continue Reading

News and Report

Just In: Court restrains INEC from receiving petition for recall of Natasha

Published

on

By

The Federal High Court, Lokoja, has granted an interim injunction restraining the Independent National Electoral Commission, INEC, from receiving petitions for the purpose of initiating a recall process against Senator Natasha Akpoti-Uduaghan.

SOCIETY REPORTERS reports that the push to recall the suspended senator intensified on Thursday, with more groups in Kogi Central throwing their weight behind the process.

However, a group of Ebira indigenes refuted the claim that the recall process was being sponsored and influenced with money by Akpoti-Uduaghan’s political opponents.

Nevertheless, the court, which gave the order on Thursday, also restricted INEC staff, agents, privies, or assigns from accepting or acting on any petition containing fictitious signatures of purported members of the Kogi Central Senatorial District and from conducting any referendum pending the determination of the motion on notice to the same effect.

The court, according to the order paper made available to newsmen on Friday morning, granted the application following an ex-parte application for an interim injunction supported by an affidavit of extreme urgency.

The court processes were sworn to by Anebe Jacob Ogirima for himself and four others who are registered voters and constituents of the Kogi Central Senatorial District of Kogi State.

However, the application was moved by Smart Nwachimere, Esq., of West-Idahosa, SAN & Co., but the case has been adjourned to May 6, 2025, for a report of service and further mention.

Reacting to the development, a pressure group, Action Collective, commended the judiciary for granting the order.

The group’s coordinator, Dr. Onimisi Ibrahim, said in his reaction that the order would further expose the impunity of some sponsored individuals behind the failed plot to recall Senator Natasha.

Continue Reading

Trending